Cargando…
Serum TSLP is a potential biomarker of psoriasis vulgaris activity
BACKGROUND: The proallergic cytokine, thymic stromal lymphopoietin (TSLP) may synergize with T cell–derived CD40 ligand (CD40L) to allow IL-23 production in patients with psoriasis. IL-23 is a central cytokine that mediates the inappropriate immune reaction in patients with psoriasis. OBJECTIVE: The...
Autores principales: | El-Ghareeb, Mohamed Ibrahim, Helmy, Afaf, Al Kazzaz, Sally, Samir, Hanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679690/ https://www.ncbi.nlm.nih.gov/pubmed/31440462 http://dx.doi.org/10.2147/PTT.S212774 |
Ejemplares similares
-
Risk and severity of psoriasis vulgaris in relation to angiotensin II type 1 receptor gene polymorphism and metabolic syndrome
por: ElGhareeb, Mohamed Ibrahim, et al.
Publicado: (2019) -
Gelsolin as a Potential Clinical Biomarker in Psoriasis Vulgaris
por: Lee, Sul Hee, et al.
Publicado: (2023) -
TSLP and TSLP receptors variants are associated with smoking
por: Semlali, Abdelhabib, et al.
Publicado: (2019) -
Role of bulge epidermal stem cells and TSLP signaling in psoriasis
por: Gago‐Lopez, Nuria, et al.
Publicado: (2019) -
Serum Prolactin Levels in Psoriasis Vulgaris
por: Handjani, Farhad, et al.
Publicado: (2014)